Cellectar Biosciences, Inc.
Nasdaq: CLRB
- Raised $25 million (2023)
- 13 clinical trials, 5 active
- Research grants: $10 million
Life science companies
Explore 33,266 biotech, pharmaceutical, medical device, CRO and CDMO companies. Filter by type, location, clinical trials, funding, FDA registrations and research focus, then see the insights or the map. Free, and new companies are added every day.
Achieve Life Sciences, Inc.
Nasdaq: ACHV
- Raised $19 million (2022)
- 31 clinical trials, 1 active
- Research grants: $5.6 million
Inhibikase Therapeutics, Inc.
Nasdaq: IKT
- Raised $1 million (2026)
- 8 clinical trials, 2 active
- Research grants: $25 million
- Founded 2025
Marker Therapeutics, Inc.
Nasdaq: MRKR
- Raised $16 million (2024)
- 7 clinical trials, 3 active
- Research grants: $14 million
Cytosorbents Corp
Nasdaq: CTSO
- Raised $745,000 (2013)
- 9 clinical trials, 2 active
- 1 FDA-registered device site
- Research grants: $8.5 million
Lyra Therapeutics, Inc.
OTC: LYRA
- Raised $50 million (2023)
- 5 clinical trials
- Research grants: $9.6 million
- Founded 2005
Annexon, Inc.
Nasdaq: ANNX
- Raised $130 million (2022)
- 16 clinical trials, 3 active
- Research grants: $2.6 million
- Founded 2011
Longeveron Inc.
Nasdaq: LGVN
- Raised $16 million (2026)
- 10 clinical trials, 1 active
- Research grants: $10 million
- Founded 2014
Celldex Therapeutics, Inc.
Nasdaq: CLDX
- Raised $63 million (2016)
- 47 clinical trials, 7 active
- Research grants: $4 million
Cognition Therapeutics Inc
Nasdaq: CGTX
- Raised $1.6 million (2018)
- 13 clinical trials, 1 active
- Research grants: $20 million
- Founded 2007
Agenus Inc
Nasdaq: AGEN
- Raised $30 million (2019)
- 35 clinical trials, 6 active
- Research grants: $1.9 million
Intuitive Surgical Inc
Nasdaq: ISRG
- 61 clinical trials, 17 active
- FDA-cleared or approved devices
- Research grants: $4.6 million
Mannkind Corp
Nasdaq: MNKD
- Raised $59 million (2013)
- 59 clinical trials, 2 active
- FDA-cleared or approved devices
- 1 FDA-registered drug site
Serina Therapeutics, Inc.
NYSE: SER
- Raised $10 million (2023)
- 2 clinical trials, 1 active
- Research grants: $4.8 million
- Founded 2017
Edwards Lifesciences Corp
NYSE: EW
- Raised $35 million (2018)
- 128 clinical trials, 46 active
- FDA-cleared or approved devices
Protagonist Therapeutics, Inc
Nasdaq: PTGX
- Raised $17 million (2015)
- 13 clinical trials, 2 active
- Research grants: $6.3 million
Dynavax Technologies Corp
- Raised $181,000 (2010)
- 25 clinical trials, 2 active
- 1 FDA-registered drug site
- Research grants: $7.4 million
Lisata Therapeutics, Inc.
Nasdaq: LSTA
- Raised $25 million (2021)
- 17 clinical trials
- Research grants: $4 million
Galera Therapeutics, Inc.
OTC: GRTX
- Raised $2.9 million (2025)
- 17 clinical trials
- Research grants: $2.2 million
- Founded 2012
Vaxcyte, Inc.
Nasdaq: PCVX
- Raised $110 million (2020)
- 9 clinical trials, 5 active
- Research grants: $392,126
- Founded 2013
Showing 40 of 33,266 companies
Load morePublished company profiles only; counts update daily. Data licences